Sugi Predict

Sugi Predict / Compounds / SCHEMBL900790

SCHEMBL900790

SCHEMBL900790

Cc1cccc2sc(-c3ccccc3)nc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.56
▸ APP P05067 2/20 0.51
▸ PKM P14618 3/20 0.49
▸ ADORA3 P0DMS8 2/20 0.47
▸ ADORA2A P29274 2/20 0.47
▸ ADORA1 P30542 2/20 0.47
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ GLA P06280 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ MAPT P10636 5/20 0.44
▸ PDCD1 Q15116 1/20 0.44
▸ CD274 Q9NZQ7 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ KDM4E B2RXH2 4/20 0.42
▸ HPGD P15428 1/20 0.42
▸ AGPAT2 O15120 1/20 0.42
▸ RAB9A P51151 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28033974 0.85 ALDH1A1 (0.51) ALDH1A1APPPKMMEN1KMT2A
SCHEMBL4798607 0.85 APP (0.58) ALDH1A1APPMEN1KMT2AGLA
SCHEMBL28033960 0.85 ALDH1A1 (0.51) ALDH1A1APPMEN1KMT2AGLA
SCHEMBL8535704 0.85 ALDH1A1 (0.60) ALDH1A1APPPKMMEN1KMT2A
SCHEMBL23761942 0.83 APP (0.50) ALDH1A1APPPKMMEN1KMT2A
SCHEMBL28033414 0.83 ALDH1A1 (0.54) ALDH1A1APPPKMMEN1KMT2A
SCHEMBL28033417 0.82 ALDH1A1 (0.49) ALDH1A1APPPKMADORA3MEN1
SCHEMBL3922398 0.81 APP (0.48) ALDH1A1APPMEN1KMT2AGLA
SCHEMBL20855087 0.81 ALDH1A1 (0.54) ALDH1A1APPPKMMEN1KMT2A
SCHEMBL27976253 0.81 ADORA3 (0.46) ALDH1A1APPPKMADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
CN-104987350-B One kind has chiral alpha aminophosphonate compound and preparation and the application of the heterocycle containing benzothiazole of antiviral activity 贵州大学 2017-12-05 — — CN disclosed
CN-106432132-A Preparation method of 2-arylbenzothiazole compound 西北师范大学 2017-02-22 — — CN disclosed
US-9029357-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2015-05-12 — — US disclosed
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET SOC CIV (FR) 2015-01-01 — — US disclosed
US-8802664-B2 Benzazole derivatives as histamine H4 receptor ligands BIOPROJECT (FR) 2014-08-12 — — US disclosed
CN-103420936-A Method for performing microwave catalysis in aqueous phase to prepare benzothiazole compound UNIV FUJIAN MEDICAL 2013-12-04 — — CN disclosed
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands BIOPROJET (FR) 2013-09-05 — — US disclosed
EP-2621916-A1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET (FR) 2013-08-07 — — EP disclosed
US-8242278-B2 Process for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-14 — — US disclosed
US-20070117812-A1 Dihydropyrimidines BAYER AKTIENGESELLSCHAFT (DE) 2007-05-24 — — US disclosed
CN-1303043-C Process for producing biaryl compound SUMITOMO CHEMICAL CO (JP) 2007-03-07 — — CN disclosed
CN-1642879-A Process for preparing diaryl compounds SUMITOMO CHEMICAL CO (JP) 2005-07-20 — — CN disclosed
US-20050096471-A1 Process for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-05-05 — — US disclosed
EP-1473286-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2004-11-03 — — EP disclosed
US-5412099-A Intermediate benzothiazolyl- and benzoxazolyl-aldehyde compounds BAYER AKTIENGESELLSCHAFT (DE) 1995-05-02 — — US disclosed
EP-0450420-B1 Dihydropyridines substituted by heterocycles, process for their preparation and their use in medicaments BAYER AG (DE) 1994-09-21 — — EP disclosed
US-5254692-A Inotropic BAYER AKTIENGESELLSCHAFT (DE) 1993-10-19 — — US disclosed
US-5200420-A Inotropic agents for cardiovascular disorders BAYER AKTIENGESELLSCHAFT (DE) 1993-04-06 — — US disclosed
EP-0450420-A2 Dihydropyridines substituted by heterocycles, process for their preparation and their use in medicaments BAYER AG (DE) 1991-10-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004181-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 ALDH1A1 2893/4885APP 3639/4885PKM 2606/4885
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 ALDH1A1 3072/4885APP 2850/4885PKM 1435/4885
US-20130231329-A1 Benzazole Derivatives as Histamine H4 Receptor Ligands HRH4, HRH3, HRH2 ALDH1A1 1305/4885APP 3386/4885PKM 2217/4885
US-20050096471-A1 Process for producing biaryl compound PPOX, CAT, TYR ALDH1A1 1191/4885APP 1198/4885PKM 1640/4885
US-20070117812-A1 Dihydropyrimidines DPYD, DHFR, TYMP ALDH1A1 405/4885APP 3089/4885PKM 969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.